SHERIDAN, WYOMING – May 7, 2025 – Baxter International Inc., a global leader in advancing surgical innovation, has announced the launch of its Hemopatch Sealing Hemostat with room temperature storage at a symposium in Vienna, Austria. This new product evolution significantly improves accessibility for surgeons, offering a practical and effective solution for controlling bleeding and preventing leakage during surgery. The product is now available for order throughout Europe, marking a key step forward in Baxter’s ongoing commitment to enhancing patient care.
Enhanced Surgical Accessibility and Efficiency
The Hemopatch Sealing Hemostat has long been recognized for its ability to support tissue sealing, dura sealing, and hemostasis across various surgical procedures. By eliminating the need for refrigeration, Baxter's latest innovation optimizes the product’s accessibility directly in the operating room. Surgeons can now rely on this ready-to-use product at room temperature, ensuring its immediate availability during critical situations.
“For over a decade, Hemopatch Sealing Hemostat has offered surgeons a reliable solution for tissue sealing, dura sealing, and hemostasis,” said Steve Wallace, president of Advanced Surgery at Baxter. “The evolution of the product to include room temperature storage is a direct result of close collaboration between surgeons and Baxter. This improvement addresses customer needs, ensuring the product is always on hand when it matters most.”
Strategic Benefits for Surgeons
Hemopatch Sealing Hemostat is an absorbable collagen pad that can be used in both open and minimally invasive surgeries. Its flexibility, ease of use, and effectiveness have made it a go-to solution for controlling mild to moderate bleeding and leakage. Real-world data from a European registry study confirms its rapid and sustainable hemostasis across numerous surgical specialties.
General Surgeon Prof. Dr. med. Selman Uranüs, a key speaker at the symposium, shared his perspective on the product’s evolution: “More than 10 years ago, I first used Hemopatch Sealing Hemostat for experimental testing. Since then, I have been using it in my daily practice because of its unique characteristics, especially in laparoscopic surgery. Eliminating the need for refrigeration and extending the shelf life are crucial improvements. It ensures we have the product available in the operating room when it matters most, and its enhanced adhesive strength supports better surgical outcomes.”
Key Features and Applications
- Room temperature storage: No refrigeration required, enabling immediate use in the operating room.
- Ready-to-use absorbable collagen pad: Designed for tissue sealing, dura sealing, and hemostasis.
- Proven effectiveness: Demonstrated rapid and sustainable hemostasis in a variety of surgical specialties.
- Flexible and easy to apply: Controlled application for precise sealing and hemostasis.
Broader Industry Impact
Baxter’s commitment to advancing surgical innovation through collaborative efforts with surgeons reflects broader trends in the healthcare sector, where operational efficiency and patient outcomes are top priorities. The ability to store Hemopatch Sealing Hemostat at room temperature eliminates logistical barriers, making it an indispensable tool in emergency situations and routine surgical procedures.
As the healthcare industry continues to demand faster, more efficient solutions, Baxter’s product evolution positions it as a key player in meeting these needs. With enhanced product features and improved accessibility, the Hemopatch Sealing Hemostat is set to make a significant impact on both operational efficiency and patient care across Europe.
Conclusion
Baxter’s introduction of the Hemopatch Sealing Hemostat with room temperature storage is a game-changing advancement in surgical care. By providing a solution that is both practical and effective, Baxter continues to lead the way in surgical innovation. To learn more about Hemopatch Sealing Hemostat, visit https://advancedsurgery.baxter.eu/hemopatch.